Status:
UNKNOWN
Nebulized Colistin for Hospital-Acquired Pneumonia
Lead Sponsor:
Mahidol University
Conditions:
Pneumonia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Nebulized Colistin for Adjunctive Therapy of Hospital-Acquired Pneumonia caused by Gram Negative Bacteria should be more effective than conventional therapy
Detailed Description
Randomized Controlled Clinical Trial in hospitalized adult patients with hospital-acquired pneumonia. The patients are allocated to conventional group or nebulized colistin group. The conventional gro...
Eligibility Criteria
Inclusion
- Adult (age\>18 years) hospitalized patient with hospital-acquired pneumonia due to Gram negative bacteria
Exclusion
- pregnancy
- lactating woman
- colistin allergy
- severe renal impairment
- epilepsy
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00920270
Start Date
June 1 2006
Last Update
June 15 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siriraj Hospital
Bangkok, Bangkok, Thailand, 10700